- Home
- AXSM vs INFA Comparison
AXSM vs INFA Comparison
Compare AXSM & INFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- INFA
- Stock Information
- Founded
- AXSM 2012
- INFA 1993
- Country
- AXSM United States
- INFA United States
- Employees
- AXSM N/A
- INFA N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- INFA EDP Services
- Sector
- AXSM Health Care
- INFA Technology
- Exchange
- AXSM Nasdaq
- INFA Nasdaq
- Market Cap
- AXSM 5.1B
- INFA 5.6B
- IPO Year
- AXSM 2015
- INFA 2021
- Fundamental
- Price
- AXSM $116.78
- INFA $24.78
- Analyst Decision
- AXSM Strong Buy
- INFA Hold
- Analyst Count
- AXSM 17
- INFA 13
- Target Price
- AXSM $175.76
- INFA $24.75
- AVG Volume (30 Days)
- AXSM 591.0K
- INFA 2.9M
- Earning Date
- AXSM 11-11-2025
- INFA 10-29-2025
- Dividend Yield
- AXSM N/A
- INFA N/A
- EPS Growth
- AXSM N/A
- INFA N/A
- EPS
- AXSM N/A
- INFA N/A
- Revenue
- AXSM $495,033,000.00
- INFA $1,662,027,000.00
- Revenue This Year
- AXSM $64.05
- INFA $5.43
- Revenue Next Year
- AXSM $56.46
- INFA $4.92
- P/E Ratio
- AXSM N/A
- INFA N/A
- Revenue Growth
- AXSM 69.83
- INFA 1.16
- 52 Week Low
- AXSM $75.56
- INFA $15.65
- 52 Week High
- AXSM $139.13
- INFA $28.14
- Technical
- Relative Strength Index (RSI)
- AXSM 47.95
- INFA 55.01
- Support Level
- AXSM $123.54
- INFA $24.76
- Resistance Level
- AXSM $130.00
- INFA $24.81
- Average True Range (ATR)
- AXSM 3.66
- INFA 0.05
- MACD
- AXSM -0.95
- INFA -0.03
- Stochastic Oscillator
- AXSM 4.51
- INFA 20.41
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About INFA Informatica Inc.
Informatica Inc provides artificial intelligence (AI) enabled data management products on a cloud native platform that connects, manages, and unifies data across multi-vendor, multi-cloud, and hybrid systems at an enterprise scale. The company's platform includes a suite of interoperable data management products that leverage the shared services and metadata of the underlying platform, including products for Data Catalog, Data Integration & Engineering, API & Application Integration, Data Quality and Observability, Master Data Management, Customer and Business 360 Applications, Governance, Access and Privacy, and Data Marketplace., allowing customers to track and understand their data. Geographically, the company generates maximum revenue from North America.